Included Health

1.1 Identity, formation, and product scope

Included Health today presents itself as a personalized, all-in-one healthcare company that combines navigation, advocacy, and care delivery. The current entity is not a simple rename of one legacy startup: it was assembled in 2021 when Grand Rounds and Doctor On Demand merged, then quickly expanded again by agreeing to acquire the original Included Health, a concierge-style platform focused on LGBTQ+ people and other underserved populations. The October 2021 rebrand turned that acquired name into the umbrella identity for the combined company. That history matters because it explains why the platform is broader than a typical care-navigation vendor. Official materials now position Included Health around urgent care, primary care, behavioral health, specialty care, and advocacy rather than a single virtual-care workflow. The solutions page frames the company's operating philosophy as “AI+EQ,” explicitly describing artificial intelligence as an enhancer of the human clinical and navigation experience rather than a replacement for it. That through-line from inclusive navigation to broader integrated care is central to how the company explains its identity today.[CO001, CO002, CO003, CO004, CO005, CO013]

1.2 Leadership continuity and governance

Leadership continuity is strongest around Owen Tripp, the Grand Rounds co-founder who became chief executive of the merged business and remained the public face of Included Health in the January 2025 Business Insider interview. Robin Glass remained publicly identified as president across the 2021 merger team and the 2024 legal-hire announcement, indicating continuity in the senior operating layer even as the company refreshed its bench after pausing IPO plans. The biggest post-May-2024 additions were Mark Flakne as CFO and Rob Guenthner as CLO, both recruited from scaled healthcare operators with experience in value-based care, transactions, and public-company processes. Board evidence is thinner than executive evidence but still usable. Included Health announced Michael Bender's appointment in November 2022, tied to Hill Ferguson's planned departure from the board as integration progressed. Public materials from that period named a seven-seat board that included former HHS secretary Kathleen Sebelius and venture-linked directors. The main governance takeaway is not obvious instability; it is concentration around Tripp and a still-opaque current investor/control picture that public sources do not fully update after the 2024-2026 executive refresh.[CO006, CO007, CO008, CO009, CO010, CO011]

1.3 Commercial scale and post-May-2024 operating proof

The strongest evidence that Included Health is still operating and expanding after May 2024 comes from named partner and customer pathways, not from financial filings. CalPERS selected Included Health in June 2024 for PPO member navigation, virtual care, and population-health support, with access beginning in January 2025; CalPERS member pages and the Included Health microsite show the service stack is active in the market, including provider search, deductible tracking, and claims tools. Blue Cross and Blue Shield of Minnesota separately expanded Doctor On Demand by Included Health into networked virtual primary care in January 2026, while Walmart remained a named employer case study for national virtual primary care rollout. Operationally, the company continues to add new service layers. The 2024 Specialty Care Clinic added rapid virtual specialty access and a 4,000-plus specialist network tied to 40-plus hospitals and health systems. Provider Connect and other 2026 releases suggest Included Health is pushing beyond generic “navigation” into default steering and care-routing infrastructure for employers and health plans. Public evidence does not prove renewal rates or utilization intensity, but it does establish ongoing delivery, enterprise distribution, and public-sector traction.[CO015, CO016, CO017, CO018, CO019, CO020]

1.4 AI roadmap and product velocity

Included Health's most visible 2025-2026 product narrative is the attempt to turn navigation into a data-rich, clinician-backed operating system. The January 2026 alternative plan design moved the company closer to a PCP-centered benefit architecture with transparent pricing and AI-powered engagement. One month earlier, Included Health had expanded Dot into a clinician-in-the-loop assistant that draws on medical history, claims, and benefits data; management said Dot had already processed more than ten billion tokens across large employer deployments. In May 2026, the company layered Provider Connect on top of this stack as a routing tool for high-quality, in-network care. These releases are still mostly company-claimed, but they are not happening in isolation. Google Research announced a nationwide randomized study with Included Health in February 2026 to evaluate conversational AI in real-world virtual care workflows, moving beyond simulation and retrospective datasets. That does not validate Included Health's product metrics yet, but it is meaningful outside-in evidence that the company is active enough — and technically credible enough — to support prospective research in live care settings.[CO014, CO025, CO026, CO027, CO028, CO029]

1.5 Capital history, private status, and adverse signals

Capital visibility is materially weaker than product or partner visibility. Public reporting shows that the company filed a confidential S-1 for a planned 2022 IPO, then stepped back as the market turned. Business Insider said Included Health was private and profitable by January 2025, with double-digit growth since 2021 and roughly 300 employers and health plans, while Tripp said the cap table consisted entirely of common stock. Public sources are much less helpful on current valuation, current total capital raised, or any debt facilities for the present company. The best public valuation point is stale: Becker's cited a $12.71 billion figure and more than 1,000 employees in October 2021, while Healthcare Dive framed the original merger as an all-stock deal between companies valued at roughly $1.34 billion and $875 million. The key adverse signal to preserve is the July 2022 restructuring, when MobiHealthNews reported a workforce reduction of less than 6%. That is not existential on its own, but it shows the company was not immune to the digital-health reset after the 2021 boom. Overall, the public record supports a view of an active, still-private platform business with meaningful partner traction and real product velocity, but it does not support precision on current valuation, headcount, or audited financials.[CO031, CO032, CO033, CO034, CO035, CO036]

2.1 Market boundary and adjacent spend

Included Health sits inside the U.S. employer-sponsored benefits market, but its real operating boundary is narrower and more useful than the total insurance market. The company sells navigation, advocacy, and virtual care through employers and health plans, so the natural economic buyer is the self-funded plan sponsor that is directly exposed to medical and pharmacy trend. KFF’s 2024 data show why this matters: 63% of covered workers and 79% of covered workers at large firms are already in self-funded plans, which means a large share of commercial coverage sits in buyer organizations that can contract directly for navigation, virtual primary care, behavioral health, and specialty support. This is also a market with persistent pain. Family premiums reached $26,993 in 2025, mental-health access still lags primary and specialty access, and employers are increasingly contracting for virtual primary care and treating telemedicine as a durable benefit layer rather than a COVID artifact. The practical market boundary therefore includes employer navigation, benefit advocacy, virtual primary care, virtual behavioral health, expert medical opinion, and specialty-care support tied to employer or health-plan benefit design. It excludes Medicare-focused care management, unaffiliated consumer direct-pay telehealth, and small fully insured benefits products where the carrier rather than the employer controls most benefit architecture. That boundary matters because Included Health’s differentiation depends on orchestrating multiple benefit touchpoints around the member instead of selling a single digital point tool.[CM001, CM002, CM003, CM004, CM005, CM006]

2.2 Sizing lenses and market structure

No public analyst source cleanly sizes an employer-only market for integrated navigation plus virtual care plus specialty support, so the right approach is to triangulate. The cleanest auditable lens is the healthcare navigation platform category, where Grand View places 2023 global revenue at $10.08 billion and Mordor places 2025 revenue at $11.40 billion, with both firms implying mid-single-digit to low-double-digit growth. Grand View also says North America is the largest regional profit pool and that large enterprises lead end use, while Mordor says employers represent 45.63% of 2025 end-user spend. That does not produce a clean Included Health SAM by itself, but it does show that the employer buyer is not peripheral to the category. The second lens is the adjacent U.S. virtual care market. Grand View estimates that market at $8.83 billion in 2024 with 32.35% CAGR through 2030, driven by primary-care and specialty shortages, chronic-disease management, and broader digital adoption. The third lens is buyer breadth: PHTI shows purchasers already covering broad sets of conditions rather than isolated tools. These lenses all point in the same direction: Included Health is not competing in a tiny benefits niche, but neither is there a single honest public TAM number that captures only its eligible employer slice. The market is large, fast-moving, and structurally overlapping, which means sizing should be presented as bounded lenses rather than a single heroic TAM claim.[CM007, CM008, CM009, CM010, CM011, CM012]

2.3 Buyer behavior, demand drivers, and adoption constraints

Buyer behavior in digital health has become more disciplined and more ruthless. PHTI’s 2024 purchasing survey says contracts are short, performance-based terms are common, and employers want proof that a product improves health, lowers cost, and spans enough indications to replace vendor sprawl. Cost pressure explains the behavior. Business Group on Health expects median employer cost trend of 9% for 2026 before mitigation, while Mercer says half of large employers are likely to shift more cost to employees and 35% plan to offer nontraditional medical plans. At the same time, employers are dealing with simultaneous shocks from obesity drugs, cancer, catastrophic claims, and higher mental-health utilization. Lockton’s claimant report shows the extreme concentration behind that pain: roughly 1% of members with more than $100,000 in annual claims account for a third of spend. These dynamics make navigation and steerage more valuable, but they also raise the bar for vendors. Employers will keep paying for digital tools only when those tools simplify the member journey, integrate with existing benefits, and create credible evidence of savings or quality improvement. Products that add one more silo or cannot prove outcomes are exactly the ones buyers say they are willing to replace. That is the core market-structure fact for Included Health: the category is growing, but growth is favoring broader, measurable platforms rather than narrow point solutions.[CM015, CM016, CM017, CM018, CM019, CM020]

2.4 Regulatory, payment, and AI backdrop

The current market backdrop is unusually supportive of virtual care access but more demanding on compliance and proof. CMS’s February 2026 FAQ extends key Medicare telehealth flexibilities through the end of 2027, preserving home-based access and continued billing for RHC and FQHC telehealth. Even though Included Health’s core market is employer-sponsored rather than Medicare, these rules still matter because they stabilize provider supply, normalize virtual workflows, and keep telehealth infrastructure investable. Mental-health parity is moving the opposite way on burden: Lockton’s MHPAEA analysis says plans need stronger comparative analyses, more data on network adequacy and reimbursement, and meaningful mental-health benefits in every relevant classification, with major design-and-application requirements hitting plan years beginning in 2026. In other words, buyers need vendors that can improve access without creating parity or network headaches. AI adds another layer. Rock Health says Q1 2026 funding remained active but concentrated and that AI is now table stakes in digital health. Consumer behavior is changing even faster: a Rock Health survey summary says 32% of adults already use AI chatbots for health information and most rely on general-purpose tools. That is a tailwind for navigation interfaces, but it also raises privacy and trust risk. The practical implication is that the winning vendors are likely to be those that combine member-facing convenience with enterprise-grade governance, clinical integration, and contracting discipline.[CM029, CM030, CM031, CM032, CM033, CM034]

2.5 Why Included Health fits this market

Included Health is directionally well aligned with where the market is going. The company already presents itself as an integrated employer solution and claims measurable trend reduction, which is exactly the language buyers now want to hear. More importantly, its product breadth maps to observed purchaser demand: primary care, mental health, obesity or metabolic support, women’s health, navigation, and specialty support all show up in public surveys as meaningful purchase categories or cost drivers. Included Health’s 2024 specialty-care launch also fits the market’s logic. Employers are treating cancer and other complex conditions as top cost categories, high-cost claims remain extremely concentrated, and specialty journeys are precisely where fragmentation creates both waste and member dissatisfaction. A model that combines navigation, expert opinion, primary care, behavioral health, and wraparound specialty support is better matched to that pain than a single-condition app. The caveat is economics, not strategic direction. Public sources do not reveal Included Health’s employer-only SAM, product-mix revenue, renewal profile, or the exact mechanism behind its claimed savings. So the correct conclusion is not that the market case is fully proven. It is that Included Health fits a large and structurally favorable demand pattern—self-funded employers trying to consolidate fragmented tools, steer members to higher-value care, and manage catastrophic specialty and pharmacy trend—while still needing diligence on actual contract economics and realized ROI.[CM036, CM037, CM038, CM039, CM040, CM041]

2.6 Exhibits

3.1 Landscape and buyer requirements

Included Health competes in a category that has shifted from isolated digital-health point solutions toward employer demand for a single benefits and care front door. Business Group on Health, Mercer, UnitedHealthcare, and Cigna all describe the same macro setup for 2026: buyers are facing elevated medical and pharmacy trend, benefits teams are stretched, and employers are increasingly willing to use steerage, alternative plans, and more prescriptive navigation to control cost. That backdrop matters because the buyer is no longer just asking whether a vendor can answer questions; the buyer is asking whether the vendor can reduce fragmentation, guide members to high-value providers, and prove economic impact. In that market, the most relevant comparison set for Included Health is not every virtual-care vendor. It is the smaller set of platforms that try to own the employee experience across navigation, clinical guidance, and cost control, plus adjacent alternatives that can win the same budget by offering deeper pharmacy or plan-design leverage.[CP001, CP002, CP003, CP004, CP005, CP006]

3.2 Direct navigation rivals

The direct rival set starts with Transcarent, Quantum Health, Rightway, and HealthJoy, with Accolade now relevant mainly as legacy capability folded into Transcarent. Transcarent is the closest integrated challenger because the Accolade deal filled its primary-care and advocacy gaps while preserving Transcarent’s pharmacy and AI narrative. Quantum remains the strongest pure-play navigation incumbent: it offers flexible deployment, strong steerage language, and mature employer messaging around claims savings, but it still overlays existing clinical assets more than it owns them. Rightway is narrower clinically, yet more economically opinionated than most rivals because it couples navigation to a transparent PBM model and a pharmacy-spend reduction story. HealthJoy sits lighter in the stack than Included Health: it is increasingly ambitious on AI and orchestration, but it still looks more like a benefits operating system and activation layer than a delivery platform with owned specialty care. This is why Included Health’s differentiation must be judged not against a single rival, but against several different ways buyers can solve the same job.[CP007, CP008, CP009, CP010, CP012, CP013]

3.3 Virtual-care and plan-design alternatives

Teladoc, BetterHelp, and Firefly are not pure navigation peers, but they are credible alternatives in the same employer budget conversation because they cover meaningful pieces of the same job-to-be-done. Teladoc Primary360 offers a mature virtual-primary-care service with nurses, care coordinators, expert opinion, and a published channel-price example through Independence Blue Cross. BetterHelp adds consumer mental-health reach, though it functions more as a substitute for therapy access than as a benefits-navigation platform. Firefly is a different kind of threat: instead of building a broad point-solution marketplace, it argues that employers should solve cost and access through a clinically integrated health plan built around primary care, specialist steerage, and risk-sharing. These alternatives matter because they can beat Included Health on one dimension at a time—virtual-care scale, packaging simplicity, or plan-design control—even if they do not replicate Included Health’s full mix of navigation, claims help, specialty support, and inclusive care.[CP028, CP029, CP030, CP031, CP032, CP033]

3.4 Differentiation, switching costs, and competitive risks

Included Health still has a coherent strategic position: it combines navigation, benefits and claims support, virtual care, specialty care, and a public inclusion story around LGBTQ+ support that few rivals foreground. Those assets give it more clinical depth than Quantum or HealthJoy and more explicit inclusion differentiation than Transcarent, Teladoc, or Firefly. But the moat is not absolute. Transcarent is now the closest breadth rival, Quantum is proving that agentic AI and provider steerage are no longer unique, Rightway can win CFOs with hard PBM economics, Teladoc can bundle virtual care at visible channel prices, and Firefly can appeal to employers who want direct plan-level control over utilization. Switching costs are real because these products connect to data feeds, care teams, and existing vendor ecosystems, yet they are not so high that buyers cannot reconsider at renewal. The durable question for Included Health is whether it can keep translating breadth and inclusion into measurable outcomes before AI-assisted navigation and clinically integrated alternatives compress the category’s advantage.[CP009, CP010, CP011, CP038, CP039, CP040]

4.1 Revenue model and pricing remain enterprise-led and mostly opaque

Included Health’s current commercial model is clearly business-to-business even though members experience it through a consumer-style app. Across the employer and health-plan pages, the company presents itself as a covered benefit sold to organizations, not as a broad self-serve subscription. The offering bundles navigation, advocacy, virtual primary care, behavioral health, specialty care, and administrative support into one contract surface, which matters financially because it pushes the company toward larger enterprise deals, multi-stakeholder implementations, and renewal-driven revenue rather than transactional telehealth alone. Public pricing remains thin. Employer-facing materials emphasize demos, integration, and outcomes, but do not publish list prices for the employer contract itself. The clearest public pricing signal is the 2026 alternative plan design: it uses a copay-first structure for members and is explicitly framed as a way to make costs predictable while improving primary-care-led routing. That makes the member’s price experience more transparent without revealing Included Health’s own realized contract pricing, take rates, or margin capture. The commercial takeaway is that Included Health appears to monetize through custom enterprise contracts, payer integrations, and performance-linked arrangements, but a buyer still needs management data to understand how much of that revenue is recurring PMPM-style platform income versus more episodic care-delivery economics.[CI001, CI002, CI003, CI004, CI032, CI051]

4.2 Public scale signals improved, but revenue is still undisclosed

The strongest 2025 financial signal is management’s statement to Business Insider that Included Health is profitable. That matters because the company had privately filed an S-1 for a 2022 IPO, pulled back when the market deteriorated, and then spent the next several years reworking its operating model. In the same interview, management said revenue has grown at a double-digit rate since 2021, that the company now works with roughly 300 employers and health plans, and that the earlier merged business had around 250 contracts and combined revenue in the hundreds of millions. Together, those disclosures support a conclusion that Included Health is operating at meaningful late-stage private-company scale even though it still withholds a current top-line figure. The company’s operating narrative is not uniformly positive. Included Health cut less than 6% of its workforce in 2022, a reminder that digital-health cost pressure reached even scaled platforms. But the later CFO and CLO hires, the strong-cash-position claim, and the statement that all shares are common stock suggest a company that used the IPO pause to simplify operations and reduce financing pressure rather than a business forced into emergency capital raising. The net is encouraging but incomplete: profitability, contract count, and leadership upgrades point in the right direction, yet an investor still lacks the audited revenue, margin, and cash-flow proof needed to know how much of the turnaround is durable operating leverage versus selective narrative disclosure.[CI005, CI006, CI007, CI008, CI009, CI023]

4.3 Predecessor funding is visible, but the combined-company valuation remains opaque

Included Health’s capital history is best understood through the two predecessor businesses. Grand Rounds announced a $175 million financing led by Carlyle in September 2020 and said it had raised more than $270 million to date while covering six million lives across more than 130 self-insured employers. Doctor On Demand announced a separate $75 million Series D two months earlier led by General Atlantic, while its 2018 SEC Form D showed another $73.999 million offering with roughly $61.999 million sold. Those disclosures confirm that both sides of the 2021 merger entered the deal with substantial venture backing, scaled payer and employer distribution, and the capital base needed to support enterprise sales and clinical expansion. The merger itself is financially frustrating from an underwriting perspective. Official announcements say it was all-stock with no fresh outside capital, and that terms were not disclosed. Trade coverage supplies only partial reference points: Grand Rounds at about $1.34 billion and Doctor On Demand at about $820 million to $875 million, which supports a low-single-digit-billions framing for the combination but not a precise exchange value. Grand Rounds’ June 2021 Form D disclosed a $15.1 million business-combination offering sold to nine investors, giving one more filing anchor but still not the full merger math. Public ownership signals also remain mixed: the CEO later said the cap table contains only common stock with no preference stack, yet the paused 2022 IPO shows liquidity ambitions without a completed exit. In short, predecessor funding is well evidenced, while the combined-company valuation history is not.[CI010, CI011, CI012, CI013, CI014, CI016]

4.4 Public ROI proofs support the value proposition more than they prove vendor economics

Included Health has a stronger public case for customer value than for its own vendor unit economics. The CalPERS contract is the clearest purchaser-level proof: roughly 400,000 PPO members are in scope, Included Health and Blue Shield put $464 million at risk over five years, and the medical-trend target steps down from 5.5% in 2025 to 3.0% in 2029. That structure is important because it shows Included Health is no longer selling only point-solution navigation; it is participating in large, multi-year arrangements where measured cost improvement is economically central to the contract. The company also has explicit customer-proof artifacts. Walmart’s multi-year virtual primary care deployment reported an 11% reduction in total cost of care, a 24% average reduction in HbA1c for diabetes users, and a 14% reduction in blood pressure for hypertension users. Provider Connect adds another company-claimed proof point: 9% savings per referral and a 92% increase in connections to top-quartile clinicians. Healthy Days and Specialty Care Clinic launches show how Included Health is trying to widen revenue mix into engagement measurement, specialty coordination, and higher-acuity support. The gap is that none of these proofs reveal Included Health’s own gross margin, clinician labor intensity, CAC, retention, or cash conversion. They validate buyer value and commercial relevance, but not yet the vendor’s full economic engine.[CI027, CI028, CI029, CI030, CI031, CI034]

4.5 Verdict: credible revenue model, credible demand, still incomplete underwriting file

Included Health’s financial picture is directionally better than many digital-health peers that chased the 2021–2022 IPO window. The company says it is profitable, says it has maintained double-digit growth, and can point to large contracts, payer integrations, and customer ROI studies that show its navigation-plus-care model resonates with sophisticated buyers. The cap-table comment about common stock only, combined with the CEO’s statement that the company did not need to raise during the IPO pause, also reduces concern that Included Health is sitting on a distorted liquidation stack or an immediate financing cliff. But the underwriting file is still incomplete. Public sources do not disclose the current revenue figure, audited financial statements, cash balance, burn, gross margin, CAC, payback, NRR, or any detailed corporate debt schedule. The missing data are not cosmetic: they determine whether today’s profitability reflects durable operating leverage, favorable one-off contract timing, or a narrow subset of the business. The adverse signals to track are the 2022 layoff, the abandoned 2022 IPO process, the lack of public audited financials, and the fact that buyer-facing savings proofs still stop short of showing Included Health’s own return profile. On current evidence, the business model and demand look real, but a financial buyer should still treat margin path, cash adequacy, and revenue quality as diligence-gated rather than proven.[CI005, CI007, CI023, CI030, CI035, CI039]

4.6 Exhibits

5.1 Integrated architecture centers on one app, one record, and shared clinical operations

Included Health’s product thesis is not that it has the best point solution in every category, but that navigation, care delivery, advocacy, and benefit design should sit inside one operating system. The strongest official proof is architectural, not just promotional: All-Included Care says members enter through one app, clinicians document in a single EHR, and the same company can answer benefits questions, route people to providers, deliver virtual visits, and escalate into specialty or second-opinion workflows. The Care Clinic and primary-care pages reinforce that this is meant to be longitudinal rather than episodic, with on-staff clinicians, PCP-to-specialist eConsults, shared follow-up, and integration with labs, pharmacies, and local providers. That closed-loop structure is the main technical differentiator versus employer-benefit stacks that bolt telehealth, navigation, and condition vendors together. The caveat is that much of the integration story still comes from company-produced materials; public technical evidence shows breadth and coherence, but only limited third-party benchmarking on how well the stack performs under load or across heterogeneous payer and provider environments.[CE001, CE002, CE003, CE004, CE005, CE007]

5.2 The clinical workflow is broad, fast, and clearly designed for human follow-through

For members, Included Health increasingly looks like a front door to many healthcare jobs rather than a narrow telemedicine product. The primary-care surfaces show a straightforward intake path—activate, pick a doctor, visit online, and return for refills, referrals, screenings, or chronic-condition follow-up. Behavioral health expands that front door into therapy and psychiatry with sub-week access, while Expert Medical Opinion handles high-acuity cases by collecting records, matching a specialist, and returning recommendations without adding separate appointments or bills. Pharmacy navigation adds another operational layer by handling prior authorization friction, savings search, refill management, and medication guidance. The practical implication is that Included Health tries to own the coordination burden after the first click, not just the appointment slot. That is a meaningful service-workflow advantage for enterprise buyers, because missed referrals and abandoned next steps destroy value in fragmented benefit stacks. The limitation is that the fastest claims and best outcome numbers remain company-reported; external validation is thinner than the surface-area map suggests.[CE005, CE006, CE008, CE009, CE010, CE011]

5.3 Dot, Provider Connect, and plan design turn navigation into routing and cost management

The most important product shift since the Grand Rounds and Doctor On Demand merger is that Included Health has moved from digital navigation plus virtual care into algorithmic routing and plan steering. Dot is presented as the orchestration layer: it uses benefits, claims, and clinical context to answer questions, guide people to the next step, and hand off to clinicians when the situation crosses a safety threshold. Provider Connect sits inside that assistant and adds a quality and cost engine that claims to personalize provider selection using billions of data points and hundreds of specialty-specific measures. Alternative Plan Design then wraps the same routing logic into incentives by putting a well-being consult and copay-first economics at the start of the member journey. CalPERS and Blue Shield add real purchaser proof that Included Health can sit inside large risk-bearing arrangements, while the 2022 ecosystem-connectivity launch shows the company is also trying to own referrals across outside vendors. Technically, this is the part of the platform with the most leverage and the most opacity: the routing stack is clearly central to differentiation, but its scoring methodology and error rates are still mostly a black box to outsiders.[CE024, CE025, CE026, CE027, CE028, CE029]

5.4 Communities, specialty care, and pharmacy broaden the stack beyond generic telehealth

Included Health’s breadth is easiest to underestimate if the company is viewed only through the lens of virtual primary care. The communities business adds targeted navigation and care coordination for LGBTQ+ and Black populations, including affirming-provider search, benefits help, social support, and confidentiality commitments. Point32Health’s rollout shows the offer can be embedded at payer level rather than marketed only as an employer DEI add-on. At the same time, Specialty Care Clinic pushes the core care model into cancer, metabolic, women’s health, and autoimmune use cases, while Expert Medical Opinion keeps a second-opinion pathway for members facing major diagnoses or surgery decisions. Pharmacy navigation rounds out the experience by handling the administrative and clinical friction around medications. The strategic result is a product map that covers navigation, routine care, complex care, and underserved-population support in one brand. The limitation is proof asymmetry: public evidence is robust on breadth and member stories, but much thinner on independent outcomes for communities and pharmacy compared with the better-publicized primary-care and purchaser-contract examples.[CE016, CE017, CE018, CE019, CE020, CE021]

5.5 Trust signals are real, but independent validation still lags the ambition of the AI stack

Included Health’s public trust posture is stronger than many digital-health peers on basic controls. The company publishes a detailed privacy policy, says vendors handling PHI must sign business associate agreements, explicitly disallows PHI marketing without authorization, maintains a bug bounty, and migrated customers toward stronger identity standards such as OpenID Connect. The medical-device consent form also usefully clarifies that the platform may rely on third-party clinical kits in virtual settings while disclaiming responsibility for those devices’ safety and performance. On AI, the most credible external quality signal is not a public benchmark dashboard but the Google Research randomized study announced in February 2026. That trial materially strengthens the validation path for Dot, yet it is still pending results, and buyers still lack public metrics on uptime, false escalations, routing precision, or audit scope for the provider-quality engine. Net: Included Health looks technically differentiated because it has linked navigation, clinical operations, and benefits data into one stack, but the product remains diligence-gated on black-box measurement, certification scope, and externally validated operating performance.[CE042, CE043, CE044, CE045, CE048, CE049]

5.6 Exhibits

6.1 Employer, payer, and channel-buyer segmentation is broad, but mostly described through curated proofs

Included Health clearly sells into more than one customer archetype. Its public site splits demand between employers and health plans, then shows how those buyers extend into public purchasers such as CalPERS and administrator channels such as Trustmark and HealthComp. On the employer side, the positioning is aimed at HR, benefits, and finance leaders who need one entry point for navigation, virtual care, advocacy, and specialty routing. On the payer side, the pitch shifts toward member satisfaction, broad access, virtual-primary-care reach, and differentiated programs for commercial, Medicare Advantage, and federal-member populations. That breadth matters because it lowers dependence on a single go-to-market motion. Included Health can land directly with self-insured employers, but it can also be embedded through health-plan contracts, TPA partnerships, or public-purchaser arrangements. The trade-off is transparency: the public record shows logos, curated case studies, and partner announcements far more often than it shows a clean breakdown of how many customers sit in each segment, how much revenue each contributes, or how durable those relationships have been at renewal.[CU001, CU002, CU004, CU005, CU006, CU009]

6.2 Named customer proof is strongest where deployment scope and outcome math are both public

The strongest named proof points are CalPERS and Walmart because both move beyond logo use into deployment scope and performance language. CalPERS gives Included Health a public-purchaser reference with roughly 400,000 PPO members, explicit accountability for navigation and virtual care, and a five-year at-risk construct tied to cost and quality. Walmart gives the company a rare employer case with rollout history plus clinical and financial outcomes: an 11% total-cost-of-care reduction, chronic-condition and preventive use beyond urgent care, and biometric improvements for diabetes and hypertension. Other named references broaden the customer map even when their proof quality is weaker. Salesforce and Windstream show that Included Health can win large or distributed employers. Point32Health, SCAN, and Blue Cross and Blue Shield of Minnesota show payer and Medicare pathways. Trustmark and HealthComp show channel leverage through administrators. The gap is that most of those proofs stop at product availability, member support design, or qualitative results rather than disclosing attach rates, renewal outcomes, PMPM economics, or audited before-and-after baselines.[CU011, CU012, CU014, CU015, CU016, CU017]

6.3 Health-plan distribution is a differentiator, especially where community or equity programs matter

Included Health’s payer channel is not just a digital-front-door story; it increasingly includes segmented communities and care-navigation programs that make the offering look more like a member-engagement and population-management layer. Point32Health’s Tufts and Harvard Pilgrim commercial members get LGBTQ+ navigation, affirming-provider matching, and support groups. SCAN Affirm uses Included Health Communities, peer support, advocacy, and community resources inside an LGBTQ+-focused Medicare Advantage plan. Blue Cross and Blue Shield of Minnesota now carries Doctor On Demand primary care inside a live health-plan network, while Compass Rose and the unnamed regional plan show that federal, commercial, and Medicare Advantage populations are also in scope. That community emphasis is a real buyer differentiator because it helps Included Health sell on equity, trust, and access rather than on generic telehealth alone. The Black Community Innovation Coalition makes the same point from the employer side. Still, public disclosure remains stronger on program design than on utilization: member counts, county-level uptake, community-program penetration, and segment-specific retention are mostly absent from the reviewed materials.[CU006, CU009, CU018, CU019, CU020, CU021]

6.4 Implementation motion centers on one front door, virtual-primary-care continuity, and escalation into higher-touch support

Across employer, payer, and TPA materials, Included Health consistently sells a similar operational promise: one point of entry, guidance before and after the visit, and handoffs when virtual care alone is insufficient. Salesforce and Windstream case studies emphasize a centralized platform or single entry point. Trustmark and HealthComp frame the product as a combined navigation-and-member-services layer that can sit on top of existing benefit plans. Blue Cross and Blue Shield of Minnesota’s live network integration and Doctor On Demand’s microsite make the service model concrete: members can establish a virtual primary-care relationship, get imaging or specialist support coordinated by a care team, and stay inside the plan’s network logic. The Solv and Bicycle partnerships extend the same pattern. Solv closes the digital-to-physical care gap for the subset of visits that need in-person follow-up, while Bicycle gives Included Health a specialist endpoint for opioid-use-disorder treatment. Public activation signals are directionally good, but they are still incomplete. Included Health publishes follow-up, adherence, and utilization lifts, yet it rarely pairs those lifts with named-customer denominators, conversion funnels, or service-level metrics.[CU010, CU024, CU025, CU027, CU028, CU036]

6.5 Durability is the weakest public dimension because retention, concentration, and complaints are only partially visible

Included Health does show public evidence that members can like the service: the company’s own testimonial page reports a 4.9-out-of-5 rating, and several customer stories emphasize reduced friction, better guidance, or better access. But the durability file is thinner than the acquisition file. None of the reviewed sources disclose NRR, GRR, logo churn, renewal cohorts, or top-customer concentration. Even the biggest references, such as CalPERS and Walmart, prove relevance more than they prove retention. That matters because navigation platforms live or die on utilization, service quality, and annual renewal confidence. The adverse evidence is also real, even if imperfect. An archived Trustpilot page showed a 1.8-out-of-5 rating in late 2025 and contained complaints about referrals, billing, glitches, and member-service responsiveness. Those reviews are self-selected and should not be mistaken for enterprise churn data, but they do show that the operational model can create member-friction risk. The bottom line is that Included Health has credible breadth and credible buyer proof, yet public data on renewal durability and customer concentration remain diligence-gated rather than proven.[CU013, CU041, CU042, CU043, CU045, CU046]

7.1 Financial opacity, valuation overhang, and harder employer buying conditions

Included Health’s commercial position is real but still hard to underwrite. Public materials clearly show an enterprise go-to-market built around employers and health plans, and Business Insider says the company now serves roughly 300 such buyers while claiming profitability and double-digit growth. That is enough to establish scale, but not enough to price risk well. The same interview confirms the company privately filed for a 2022 IPO and then stepped back, while current 2026 materials still avoid a fresh company-wide valuation, public revenue figure, or disclosed contract economics. That combination creates classic late-stage private-company overhang: investors know the business is substantial, but cannot tell whether the valuation reset has already happened or is merely deferred. The buyer side is also getting tougher. Employer-benefits research and vendor commentary all point in the same direction: purchasers are cutting low-value vendors, re-running RFPs, and demanding simplicity plus measurable outcomes rather than engagement theatre. Included Health’s own playbook implicitly agrees that fragmented point solutions are failing buyers. That makes the company’s integrated story strategically sensible, but it also means sales cycles, renewals, and budget approvals are likely to get more demanding just as the company is expanding scope into plan design and deeper at-risk enterprise programs. The commercial risk is not lack of demand; it is proving differentiated ROI fast enough to defend a still-opaque late-stage valuation.[CR001, CR002, CR003, CR004, CR005, CR006]

7.2 Telehealth policy, reproductive privacy, and AI liability keep residual risk high

Included Health benefits from a friendlier policy baseline than many investors feared, but the legal footing is still temporary in several places that matter. HHS says many Medicare telehealth flexibilities now run through the end of 2027, which buys time for virtual-care operators. That is helpful, but it does not fully close risk because the controlled-substance prescribing flexibilities run only through the end of 2026 and remain a specific dependency for telemedicine workflows. For a platform that still depends on virtual primary care access, changing federal rules on reimbursement, eligible providers, or remote prescribing could alter utilization, pricing, or clinical workflow design faster than enterprise contracts renew. Privacy risk is also not theoretical. HHS says a Texas court vacated most of the reproductive-health privacy rule, and Fisher Phillips says the result lands directly on employer-sponsored plans and providers. Separate employer-benefit coverage shows that abortion-travel programs are common but often poorly administered, with only a minority using third-party administration. EPIC adds that abortion-related digital traces can come from searches, apps, and other data exhaust that sit outside narrow healthcare settings. Layer in Included Health’s AI roadmap, which draws on medical history, claims, and benefits data, and the risk stack gets heavier: the company must manage HIPAA business-associate duties, fragmented oversight outside FDA-cleared tools, and unresolved malpractice or product-liability questions if clinical decision support starts influencing care at scale.[CR032, CR033, CR034, CR035, CR036, CR037]

7.3 Merger inheritance, product sprawl, and customer dependence raise execution risk

Included Health is now operating the accumulated complexity of several strategic moves at once: the Grand Rounds–Doctor On Demand merger, the acquisition of the original Included Health, payer and public-sector implementations, specialty-clinic expansion, AI-driven member guidance, and alternative plan design. None of those moves is irrational on its own. In fact, they all fit the company’s thesis that navigation, care delivery, and steerage have to be integrated to win. The problem is that each expansion also adds implementation paths, data flows, clinical protocols, and compliance surfaces that have to work together reliably across employers, health plans, and individual members. The company’s own account of the 2021 merger emphasizes speed, saying it closed in less than two months. That is impressive, but fast combinations often leave long tails of product, org-design, and systems integration work. The 2022 layoffs show some evidence of reset pressure, while the 2024 CFO and CLO hires suggest a business still building the leadership muscle needed for large contracts and complex transactions. Public customer proofs from CalPERS, Blue Cross Minnesota, and Walmart are encouraging, yet they also underscore dependence on sophisticated large accounts that can demand outcome guarantees, service levels, and implementation quality that are hard to sustain if too much growth is concentrated in a narrow set of renewals or launches.[CR009, CR010, CR011, CR020, CR021, CR022]

7.4 Residual-risk view and practical kill criteria

The top-line risk view is that Included Health probably has a real product-market fit with large employers and plans, but the residual risk remains high because public proof is stronger on customer anecdotes than on underwriting-grade disclosure. The company deserves credit for building an integrated platform in a market that is clearly punishing fragmented solutions. It also deserves some credit for hiring finance and legal leadership, for winning accounts such as CalPERS, and for pursuing clinician-in-the-loop designs instead of pure automation theatre. Those are meaningful mitigants. They do not close the file. A cautious investor should still treat five issues as thesis-break territory: renewed slippage in enterprise renewals, failure to show credible concentration data, rollback or tightening of telehealth policy, a privacy or AI-safety event involving sensitive claims-and-benefits data, or continued inability to produce independent outcomes evidence that travels beyond company-selected case studies. If diligence finds that the top accounts carry too much of the revenue base, that tele-prescribing exposure is material, or that AI governance is thinner than the marketing implies, the current story becomes much more fragile. The next diligence round should therefore focus less on another glossy ROI claim and more on concentration, policy dependency, incident history, and truly independent evidence of clinical and financial durability.[CR018, CR019, CR034, CR035, CR044, CR045]

7.5 Exhibits

8.1 Disclosed anchor and current status: credible private scale, no fresh price discovery

The cleanest starting point for Included Health valuation is what public evidence does not say. Official 2021 merger materials confirm the combination of Grand Rounds and Doctor On Demand, but they do not disclose transaction terms, so the exact merger valuation is not a hard public fact in the retained source set. Accessible 2021 coverage still makes the direction clear: the merger was treated as a multibillion-dollar digital-health combination, and contemporaneous reporting pegged the standalone businesses at roughly $1.34B for Grand Rounds and about $0.82B-$0.88B for Doctor On Demand. In other words, investors should treat the often-repeated mid-single-digit-billion 2021 story as a high-water narrative rather than a disclosed, current underwriting mark. What is current and more useful is the 2025-2026 operating signal stack. Included told Business Insider it is private, profitable, and growing double digits, with about 300 employers and health plans, and it said it did not need to raise capital after shelving the 2022 IPO. PitchBook still shows the company as private with a secondary-private latest deal type, while Crunchbase’s archived profile still lists unicorn status and Series E as the last funding type. Official company announcements, the live CalPERS microsite, and Google Research’s collaboration note all point the same way: Included is still operating, still shipping products, and still relevant to major enterprise buyers. That combination supports a still-private, likely unicorn-scale status; it does not support inventing a live 2026 mark.[CV001, CV002, CV003, CV004, CV005, CV006]

8.2 Comparable context: current public comps and M&A set a much lower, but still usable, range

The most relevant precedent in navigation is no longer a frothy 2021 growth round; it is the 2025 Transcarent-Accolade transaction. Transcarent paid $621M, or $7.03 per share, for Accolade, a roughly 110% premium to the pre-deal close. Yet even with that premium, the deal implied only about a 1.5x revenue multiple on Accolade’s last reported fiscal-year revenue. That is the single most important adverse reference point in this chapter: a scaled navigation asset with public-company history and broad client reach still cleared at a modest multiple. Stat’s framing that public markets had punished companies like Accolade reinforces that this was a compression-era deal, not a premium growth benchmark. The public comp set widens the band but does not erase that discipline. Teladoc, the mature public virtual-care comp, trades around 0.57x EV or sales despite billions of revenue because growth and profitability remain challenged. Omada, a healthier and smaller public chronic-care platform, sits closer to 2.8x EV or revenue. Hinge, the best-in-class growth comp in digital health, is the real upper bound at roughly 6x EV or revenue, but it earns that band with 47% growth, high margins, cash generation, and clean public-company predictability. Fierce’s HLTH25 takeaway is therefore crucial: the IPO window is open again, but only for companies with visible financial discipline. Included may deserve a premium to Accolade if its integrated model is genuinely stronger, but absent disclosed numbers, it does not deserve to be assumed into Hinge territory by default.[CV017, CV018, CV019, CV020, CV021, CV022]

8.3 Scenario analysis and valuation stance: still-unicorn quality, but the price remains the whole debate

Because Included has not disclosed current revenue, margin, or a fresh financing round, the right analytic move is not to declare a mark but to price scenarios. The bear case assumes Included behaves more like a compressed navigation asset than a premium software compounder: modest growth proof, limited public cash-flow transparency, and investor skepticism around category outcomes. That points toward roughly 1-2x revenue, which would matter a great deal if current revenue is lower than bullish private-market chatter assumes. The base case credits what is publicly positive—profitability, continued product shipping, and large-customer proof—while still respecting that there is no recent market-clearing primary price. On that basis, a 2.5-4.0x revenue band is the most defensible diligence screen. The bull case exists, but only conditionally. To justify 5-6x revenue and revisit the 2021 high-water narrative, Included would need to look much more like Hinge than like Accolade: audited strong growth, durable gross margins, predictable renewals, and evidence that integrated navigation plus virtual care creates unusually strong buyer economics. Until that proof exists, the latest defensible stance is not that Included is cheap or broken; it is that the company likely remains a still-private unicorn-scale asset whose fair value is highly price sensitive. If a seller anchors on old-cycle expectations, the stance is stretched. If entry is materially below the old peak and management can open the data room on revenue quality, the stance can move toward fair.[CV034, CV035, CV036, CV037, CV038, CV039]

8.4 Recommendation and diligence gates: Research-More unless management can turn signals into numbers

The recommendation for Included Health is Research-More. That call is not a quality dismissal; it is a valuation-discipline decision. The retained evidence shows a real company with current operations, customer proof, product shipping, and a profitability signal. It also shows that the digital-health market now rewards only companies that can present clean revenue, margin, and cash-generation evidence. Included has not yet done that in public. As a result, there is no defensible basis for paying a premium growth multiple simply because the company stayed private through the reset. The valuation stance is therefore price-sensitive and, at any entry anywhere near the old pandemic-era high-water narrative, stretched. The path to an investable view is concrete. Management needs to provide a current ARR or revenue bridge, gross margin and free-cash-flow proof, customer renewal and cohort-savings evidence, and a current capitalization table or secondary-price history. If those materials confirm durable profitable growth and a relatively clean common-stock structure, Included can migrate from research-more toward a structured diligence or track-positive stance. If profitability reverses, a CalPERS or Walmart-class proof account disappoints, or a new financing surfaces below prior implied expectations, the thesis should break quickly. In short: the company likely still matters, but the price cannot be separated from the missing evidence.[CV016, CV040, CV041, CV042, CV043, CV044]